Lip'ral-SSR 
| Lip'ral-SSR |
|
|
|
|
Breakthrough Oral Controlled Release Technology For Superior Controlled Therapeutics of Insoluble Drugs
Lip'ral Synchronized Solubilizer Release (SSR) is an extension of the Lip'ral technology platform superimposing controlled release aspects while preserving the solubilizing power and absorption improvement of Lip'ral technology. Lip'ral-SSR synchronizes the release of the insoluble drug and solubilizers and is ideally suited for drugs that require solubilization and controlled release. Click Here for a Detailed Presentation Conventional controlled release technologies have been designed primarily for water soluble drugs. These technologies can be inherently inefficient for delivery of water insoluble drugs due to inadequate or pH sensitive solubilization and release, and due to "absorption window" limitations. Such limitations can result in inadequate absorption or often leading to reduced efficacy.
Consider LipidScreen
for your target compound.
|
||||
pH-independent solubilization: Ideal for acidic and basic drugs requiring consistent absorption throughout the gastrointestinal tract for safety or efficacy. 
Optimization: Utilizes a wide range of proprietary compositions with bioacceptable excipients specifically designed for the physicochemical properties and pharmacokinetic requirements of a particular drug
Dosage Form Flexibility: In combination with Lipocine's solid lipid dispersion technology, Nanosplode, supports a wide variety of dosage form configurations including capsules, tablets, beads and multicomponent systems for a combination of different release profiles
Ease of Manufacturing: Uses conventional manufacturing processes that are easy to scale-up and commercialize, thus reducing time to market.
Improved bioavailability/reduced dose
Reduced dosing frequency/improved patient compliance
Targeted absorption or chronotherapeutic release
